Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Earnings Preview
Yahoo/Zacks.com
Thursday, April 21, 2011 - 6:48pm
tags:
Bristol-Myers Squibb, earnings
Report: GSK mulls deal for India vaccines unit
Fierce Pharma
Thursday, April 21, 2011 - 11:49am
tags:
vaccines, GSK, M&A, Biological E, India
Incyte and YM Biosciences in Race to Market Strongest JAK Inhibitor
Seeking Alpha
Thursday, April 21, 2011 - 11:46am
tags:
JAK inhibitors, YM BioSciences, Incyte, myelofibrosis
AEterna Zentaris Looks Ready to Make New Highs
Seeking Alpha
Thursday, April 21, 2011 - 11:01am
tags:
Aeterna Zentaris, perifosine
Amgen says it will pay dividend starting in 2Q
Yahoo/AP
Thursday, April 21, 2011 - 10:56am
tags:
dividends, Amgen
How Do These Pharmas Really Boost Their Returns?
Motley Fool
Thursday, April 21, 2011 - 10:56am
tags:
Merck, Pfizer, Abbott Laboratories, GSK, ROE
Should You Sell Abbott Labs Today?
Motley Fool
Thursday, April 21, 2011 - 10:37am
tags:
Abbott Laboratories
Titan Should Be on the Biotech Watch Lists Right Now
Seeking Alpha
Thursday, April 21, 2011 - 9:54am
tags:
Titan, Novartis, Fanapt
Biogen revenue, profit up in Q1
Bizjournals.com
Thursday, April 21, 2011 - 9:50am
tags:
Biogen Idec, earnings
Depomed: Light-Risk Small Pharma With Huge Potential
Seeking Alpha
Thursday, April 21, 2011 - 9:49am
tags:
Depomed
New generics quickly grab 80% of sales volume
Fierce Pharma
Thursday, April 21, 2011 - 9:25am
tags:
prescription data, generics
Roche's Genentech Sues Novartis Unit Claiming Infringement of Valcyte Drug
Bloomberg
Thursday, April 21, 2011 - 9:23am
tags:
Genentech, Novartis, Valcyte, generics, patents, AIDS
Merck, Vertex Prep for Hep C Drug Panels
TheStreet.com
Thursday, April 21, 2011 - 9:21am
tags:
Merck, Vertex Pharmaceuticals, hepatitis C, FDA, Boceprevir, Telaprevir, advisory panels
Pfizer, Shanghai Pharma Agree to Explore China Cooperation
Bloomberg
Thursday, April 21, 2011 - 9:19am
tags:
Pfizer, China, Shanghai Pharmaceutical
Gilead Q1 profit dips to $651.1M
Bizjournals.com
Wednesday, April 20, 2011 - 7:07pm
tags:
earnings, Gilead Sciences
Amgen Beats on Top and Bottom Lines, but Shares Drop
Bizjournals.com
Wednesday, April 20, 2011 - 7:00pm
tags:
Amgen, earnings
Dynavax gets $6M for start of human tests of lupus treatment
Bizjournals.com
Wednesday, April 20, 2011 - 6:55pm
tags:
lupus, GSK, Dynavax, DV1179
Turnaround at Johnson & Johnson? Let's Do Some Math.
Motley Fool
Wednesday, April 20, 2011 - 6:54pm
tags:
JNJ
CROs scramble as Big Pharma lines up strategic partnerships
Fierce Biotech
Wednesday, April 20, 2011 - 12:20pm
tags:
CROs, Big Pharma, R&D, Covance, PPD, Parexel, Charles River Laboratories, ICON, Kendle, Quintiles
J&J defends executive pay to institutional investors
Fierce Pharma
Wednesday, April 20, 2011 - 12:07pm
tags:
JNJ, executive pay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.